Home About Us Contact Us

 

Table of Content - Volume 11 Issue 1 - July 2018


 

A study of the prevalence of complications of diabetes at tertiary health care centre

 

Maddela Gopinath1, Sanjay M Mundkar2*

 

1,2Associate Professor, Department of General Medicine, Mahavir Institute of Medical Sciences, Vikarabad, Telangana, INDIA.

Email: drmundkarsanjay@gmail.com

 

REFERENCES

  1. Shetty P. Public health: India’s diabetes time bomb. Nature. 2012;485:S14–16.
  2. International Diabetes Federation. IDF Diabetes Atlas, 7 ed. Brussels, Belgium: International Diabetes Federation, 2015. http://www.diabetesatlas.org.
  3. WHO. World Health Day 2016: Diabetes. World Health Organization. 2016http://www.who.int/campaigns/world-health-day/2016/event/en/ (accessed February 28, 2016)
  4. A. S. Fauci, D. L. Kasper, D. L. Longo et al., Harrison’s: Principles of Internal Medicine, McGraw-Hill, New York, NY, USA, 17th edition, 2008.
  5. M. von Korff, W. Katon, E. H. B. Lin et al., “Potentially modifiable factors associated with disability among people with diabetes,” Psychosomatic Medicine, vol. 67, no. 2, pp. 233–240, 2005.
  6. E. B. Rimm, J. Chan, M. J. Stampfer, G. A. Colditz, W. C. Willett, and R. E. Laporte, “Prospective study of cigarette smoking alcohol use, and the risk of diabetes in men,” British Medical Journal, vol. 310, no. 6979, pp. 555–559, 1995.
  7. P. H. Wise, F. M. Edwardes, R. J. Craig et al., “Diabetes and associated variables in the South Australia Aboriginal,” Australian and New Zealand Journal of Medicine, vol. 6, no. 3, pp. 1991–1996, 1976.
  8. N. V. Emanuele, T. F. Swade, and M. A. Emanuele, “Consequences of alcohol use in diabetics,” Alcohol Research and Health, vol. 22, no. 3, pp. 211–219, 1998.
  9. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M: Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 2001, 44(Suppl 2(2)):S3-13.
  10. LeRoith D, Fonseca V, Vinik A: Metabolic memory in diabetes--focus on insulin. Diabetes Metab Res Rev 2005, 21(2):85-90.
  11. Turner RC, Holman RR: Lessons from UK prospective diabetes study. Diabetes Res Clin Pract 1995, 28(Suppl(7)):S151-157.
  12. Wang W, Fu CW, Pan CY, Chen W, Zhan S, Luan R, Tan A, Liu Z, Xu B: How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 2009, 12(6):923-929.
  13. Liu ZL, Fu CW, Luan RS, Zhan SY, Chen WQ, Wang WB, Xu B: The impact of complication on quality of life among diabetic patients in urban China. Chin J Epidemiol 2008, 29(10):1029-1033.
  14. Solli O, Stavem K, Sonbo Kristiansen I: Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes 2010, 8(1):18.
  15. Linda SG, William HH, Smith PJ: Mortality in Non-Insulin-Dependent Diabetes[A]. National Diabetes Data Group. Diabetes in America. Bethesda 2nd edition. 1995. NIH Publication NO.9521468.
  16. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson J, Agardh E: Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000, 78(4):374-385.
  17. Reiber GE, Boyko EJ, Smith DG: Lower extremity foot ulcers and amputations in diabetes[A]. National Diabetes Data Group. Diabetes in America. Bethesda 2nd edition. 1995. NIH Publication NO.9521468
  18. Asrat Agalu Abejew, Abebe Zeleke Belay, Mirkuzie Woldie Kerie. Diabetic Complications among Adult Diabetic Patients of a Tertiary Hospital in Northeast Ethiopia. Hindawi Publishing Corporation Advances in Public Health Volume 2015, Article ID 290920, 7 pages http://dx.doi.org/10.1155/2015/290920.